These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36799361)

  • 1. Awareness, perception and utilization of a mobile health clinic by people who use drugs.
    Grieb SM; Harris R; Rosecrans A; Zook K; Sherman SG; Greenbaum A; Lucas GM; Page KR
    Ann Med; 2022 Dec; 54(1):138-149. PubMed ID: 36799361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health workers' perceptions and experiences of using mHealth technologies to deliver primary healthcare services: a qualitative evidence synthesis.
    Odendaal WA; Anstey Watkins J; Leon N; Goudge J; Griffiths F; Tomlinson M; Daniels K
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011942. PubMed ID: 32216074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telehealth to increase healthcare access; perspectives of people who use drugs.
    Papalamprakopoulou Z; Ntagianta E; Triantafyllou V; Kalamitsis G; Dharia A; Dickerson SS; Hatzakis A; Talal AH
    BMC Med Inform Decis Mak; 2024 Oct; 24(1):306. PubMed ID: 39425182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobile low-threshold buprenorphine integrated with infectious disease services.
    Rosecrans A; Harris R; Saxton RE; Cotterell M; Zoltick M; Willman C; Blackwell I; Bell J; Hayes D; Weir B; Sherman S; Lucas GM; Greenbaum A; Page KR
    J Subst Abuse Treat; 2022 Feb; 133():108553. PubMed ID: 34238629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile clinics for opioid use disorders: What they do and how they do it. A qualitative analysis.
    Davis MT; Tschampl C; Hodgkin D; Regis C; Taveras E; Plant B; Reilly B; Horgan C
    J Subst Use Addict Treat; 2024 Sep; 164():209428. PubMed ID: 38879017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "We want everything in a one-stop shop": acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs.
    Bartholomew TS; Andraka-Cristou B; Totaram RK; Harris S; Doblecki-Lewis S; Ostrer L; Serota DP; Forrest DW; Chueng TA; Suarez E; Tookes HE
    Harm Reduct J; 2022 Dec; 19(1):133. PubMed ID: 36463183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing stigma: Health and social worker regard towards working with people using illicit drugs in Athens, Greece.
    Temenos C; Koutlou A; Kyriakidou S; Galanaki S
    Harm Reduct J; 2024 Sep; 21(1):175. PubMed ID: 39327583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic.
    Wang L; Weiss J; Ryan EB; Waldman J; Rubin S; Griffin JL
    J Subst Abuse Treat; 2021 May; 124():108272. PubMed ID: 33771276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to Healthcare for People Who Inject Drugs: A Survey at a Syringe Exchange Program.
    Miller-Lloyd L; Landry J; Macmadu A; Allard I; Waxman M
    Subst Use Misuse; 2020; 55(6):896-899. PubMed ID: 31902293
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan.
    Rosenkranz M; Kerimi N; Takenova M; Impinen A; Mamyrov M; Degkwitz P; Zurhold H; Martens MS
    Harm Reduct J; 2016 Jan; 13():3. PubMed ID: 26817827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
    Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
    Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Aboriginal Community-Controlled Health Organization model of service delivery: qualitative process evaluation of the Tulku wan Wininn mobile clinic.
    Beks H; Mitchell F; Charles JA; McNamara KP; Versace VL
    Int J Equity Health; 2022 Nov; 21(1):163. PubMed ID: 36384739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care embedded within permanent supportive housing for people who use substances: A qualitative study examining healthcare access in Vancouver, Canada.
    MacKinnon L; Kerman N; Socías ME; Brar R; Bardwell G
    Health Soc Care Community; 2022 Nov; 30(6):e5062-e5073. PubMed ID: 35852403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
    Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
    Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration.
    Ward KM; McCormick SD; Sulkowski M; Latkin C; Chander G; Falade-Nwulia O
    Int J Drug Policy; 2021 Feb; 88():103019. PubMed ID: 33160152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.